BURLINGTON, Mass. & WESTBOROUGH, Mass.--(BUSINESS WIRE)--Continuum Health Partners, the network of five prestigious hospitals and academic medical centers in Manhattan and Brooklyn, including Beth Israel Medical Center and St. Luke’s and Roosevelt Hospitals, has chosen to use IntrinsiQ’s IntelliDose® clinical oncology software with eClinicalWorks unified electronic medical record (EMR) and practice management (PM) system to support its major expansion of cancer care services. Continuum has expanded its relationship with eClinicalWorks, recently purchasing an additional 150 licenses.
Beth Israel Medical Center and St. Luke’s and Roosevelt Hospitals are the cornerstones of Continuum Cancer Centers of New York (CCCNY), the health network’s unified cancer programs. CCCNY treats more than 6,000 new cancer patients and has over 250,000 patient visits per year across locations throughout the New York City area. It’s one of the largest and most comprehensive multi-site cancer programs in the Northeast and delivers a comprehensive range of diagnostic and therapeutic services.
“In our fast-paced oncology settings, we need a specialized solution that fully integrates with eClinicalWorks - our health network EMR. IntelliDose gives our oncologists clinical tools to manage chemotherapy regimens and share optimal treatment plans that reflect our collective expertise,” said Dr. Ronald H. Blum, director, Cancer Centers and Programs, Beth Israel Cancer Center. “Using IntelliDose with eClinicalWorks, we can build a complete record of patient care that is shared with the entire Continuum care team.”
Continuum chose IntelliDose, IntrinsiQ’s leading chemotherapy management system, to create consistent clinical treatment plans across its multiple cancer care sites and reach the highest levels of clinical and operational excellence.
IntelliDose streamlines the manual process of chemotherapy regimen calculations into electronically verified orders. In combination with eClinicalWorks, IntelliDose saves crucial time and revenue by capturing charges, drug administrations and waste, inventory records and nursing notes, all in the course of delivering high-quality patient care.
Continuum has implemented eClinicalWorks unified EMR/PM system with the goals of streamlining the clinical processes and promoting patient safety while reducing costs. The network is also using eClinicalWorks Electronic Health eXchange (eEHX) to create a community record that will enable physicians to have access to patients’ vital health information and allow physicians to exchange data more effectively.
Additional Quotes
“IntelliDose was created by oncologists to manage the specific demands of complex chemotherapy treatments,” said Girish Kumar Navani, CEO and co-founder of eClinicalWorks. “IntrinsiQ’s deep understanding of the medical oncology specialty seamlessly enhances how we at eClinicalWorks serve our customers. We have also had a great partnership with Continuum, which has recently expanded to include an additional 150 licenses.”
“The pace of change and the administrative complexity in oncology is skyrocketing as therapies become more personalized and health reform efforts invite more stakeholders into the decision-making process,” said Jeff Forringer, president of IntrinsiQ. “Our clients are using IntelliDose to set the standard for excellence in care and adapt to changes in cancer care.”
“We made a strategic investment in eClinicalWorks and needed to extend its benefits to our medical oncologists. We chose IntelliDose to meet their specialized clinical needs and our enterprise integration requirements,” said Colleen Lyons, IT director, Continuum Health Partners. “The integration lets our oncologists use patient information from eClinicalWorks when they are making treatment decisions for patients and ensures that the cancer treatment information is part of the patient’s complete history of care.”
About IntrinsiQ
IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details from more than 750 oncologists, for nearly 20,000 patients, creating a database unrivaled in accuracy, detail and timeliness of information about the medical oncology care process. IntelliDose ensures patient safety though automation and standards designed to meet the needs of a specific practice, saving staff time, maximizing reimbursement and reducing operating costs. IntelliDose interfaces with leading EMR and hospital information systems, extending existing or planned technology investments to include cancer patient management. For more information, visit www.intrinsiq.com.
About eClinicalWorks
eClinicalWorks® is a privately held leader in the ambulatory clinical systems market. The company's unified electronic medical record (EMR) and practice management (PM) solutions are proven for every market segment: large practice groups, including Massachusetts eHealth Collaborative (MAeHC), Electronic Health Records of Rhode Island (EHRRI) and the New York City Department of Health and Mental Hygiene, as well as medium, small and solo practices regardless of specialty. The company enjoys high profitability with a five-year compounded growth rate of more than 100 percent year-to-year. With an established customer base of more than 50,000 providers and 225,000 healthcare professionals across all 50 states, eClinicalWorks has been awarded multiple top industry honors including being named to the Inc. 5000 in 2009, 2008 and 2007. Based in Westborough, Mass., eClinicalWorks has additional offices in New York City, Pleasanton, Calif. and Alpharetta, Ga. More information on eClinicalWorks can be found at www.eclinicalworks.com or by calling 866-888-6929.